Pulse Biosciences, Inc. Selling, General and Administrative Expense
Pulse Biosciences, Inc. (PLSE) reported Selling, General and Administrative Expense of $8.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- Pulse Biosciences, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $8.46M, a 3.30% increase year-over-year.
- Pulse Biosciences, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $6.59M, a 14.75% decline year-over-year.
- Pulse Biosciences, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $7.33M, a 23.64% decline year-over-year.
- Pulse Biosciences, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $8.78M, a 47.53% increase year-over-year.
- Pulse Biosciences, Inc. selling, general and administrative expense for fiscal 2025 was $32.03M, a 33.89% increase from fiscal 2024.
- Pulse Biosciences, Inc. selling, general and administrative expense for fiscal 2024 was $23.92M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.46M 10-Q · filed 2026-08-06 | $15.05M 10-Q · filed 2026-08-06 | $22.38M derived: sum of 3 quarters · filed 2026-08-06 | $31.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $6.59M 10-Q · filed 2026-05-14 | $13.92M derived: sum of 2 quarters · filed 2026-05-14 | $22.70M derived: sum of 3 quarters · filed 2026-05-14 | $30.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $7.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $16.11M derived: sum of 2 quarters · filed 2026-02-19 | $24.30M derived: sum of 3 quarters · filed 2026-08-06 | $32.03M 10-K · filed 2026-02-19 |
| 2025-09-30 | $8.78M 10-Q · filed 2025-11-05 | $16.97M derived: sum of 2 quarters · filed 2026-08-06 | $24.70M 10-Q · filed 2025-11-05 | $34.30M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $8.19M 10-Q · filed 2026-08-06 | $15.92M 10-Q · filed 2026-08-06 | $25.52M derived: sum of 3 quarters · filed 2026-08-06 | $31.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $7.73M 10-Q · filed 2026-05-14 | $17.33M derived: sum of 2 quarters · filed 2026-05-14 | $23.28M derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $9.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $15.55M derived: sum of 2 quarters · filed 2026-02-19 | $23.92M 10-K · filed 2026-02-19 | |
| 2024-09-30 | $5.95M 10-Q · filed 2025-11-05 | $14.32M 10-Q · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |